S-CHOice Cell Line Expression Technology
Source: Samsung Biologics
As the world's leading CDMO company, Samsung Biologics has been making innovative moves. We proudly present our official launch of Samsung Biologics’ proprietary cell line, S-CHOice, a high-performing technology to start your successful therapeutics development journey. We can now offer our clients even more promising options in bringing their molecule faster and better to the market with world-class client satisfaction. Please enjoy our virtual launch ceremony to learn more.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Samsung Biologics
This website uses cookies to ensure you get the best experience on our website. Learn more